Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15  ng/mL in patients with breast cancer: a systematic review and meta-analysis

ConclusionsAn elevated sHER2 ECD level with a cut-off value of 15  ng/mL was associated with poor clinical prognosis in patients with BC. Future studies should be conducted to reduce confounding and explore the mechanism.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research